Newron develops and commercializes novel therapies for the treatment of central nervous system diseases and cognitive disorders.
Business Model:
Revenue: $6.5M
Employees: 11-50
Address: Via Ludovico Ariosto 21
City: Bresso
State: lombardy
Zip: 20091
Country: IT
Newron develops and commercializes novel therapies for the treatment of central nervous system diseases and cognitive disorders.
Contact Phone:
Contact Email:
Listed Exchange:
SIX Swiss Exchange
IPO Date:
12/22/2006
Ticker Symbol:
NWRN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2015 | Post-IPO Equity | $22.8M | 11/2015 | Post-IPO Equity | $5.4M | 12/2010 | Post-IPO Equity | $3.7M | 10/2016 | Post-IPO Equity | $26.7M | 10/2018 | Debt | $45.5M |
EIB |
4/2002 | Venture Round | 3 | $22M |
Apax Partners 3i Group Atlas Venture Apax Partners 3i Group Atlas Venture |
10/2005 | Series B | 5 | $8.4M |
TVM Capital 3i Group HBM Partners Apax Partners Atlas Venture TVM Capital TVM Capital 3i Group HBM Partners Apax Partners Atlas Venture TVM Capital |
9/2017 | Private Placement | $27.8M | 9/2017 | Post-IPO Equity | $27.9M | 11/2009 | Post-IPO Equity | $7.8M | 10/2016 | Equity | $26.6M | 1/1999 | Venture Round | 1 | - |
3i Group 3i Group |
8/2012 | Post-IPO Equity | $4.9M | 1/1999 | Venture Round | 1 | - |
3i Group 3i Group |
---|
Announced Date | Name | Price |
---|---|---|
6/2012 | NeuroNova | |
2/2008 | Hunter-Fleming Ltd |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|